About 30 Percent wth Epithelial Ovarian Cancer Survive Long-term

Share this content:
About thirty percent of women with epithelial ovarian cancer survive for more than 10 years, including some with high-risk disease.
About thirty percent of women with epithelial ovarian cancer survive for more than 10 years, including some with high-risk disease.

About thirty percent of women with epithelial ovarian cancer survive for more than 10 years, including some with high-risk disease, according to a study published in Obstetrics & Gynecology.

Rosemary D. Cress, Dr.P.H., from the University of California Davis, and colleagues used the California Cancer Registry to examine characteristics associated with long-term survival for epithelial ovarian cancer patients.

The authors compared characteristics of long-term survivors (more than 10 years) with those who survived less than two years, at least two but no more than five years, and at least five but no more than 10 years.

RELATED: IP/IV Chemotherapy Associated with Improved Survival in Ovarian Cancer

The researchers found that 31 percent of the 11,541 patients survived more than 10 years. Significant predictors of long-term survival included younger age, early stage, low grade, and non-serous histology. Women with high-risk cancer were also included among long-term survivors.

"Long-term survival is not unusual in patients with epithelial ovarian cancer, even in those with high-risk disease," the authors write.

"Many of the prognostic factors are well known, but it remains to be determined why some patients with advanced-stage high-grade cancers survive longer than others with the same histology. These findings are important for patient counseling."

Reference

  1. Cress RD, Chen YS, Morris CR, et al. Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer. Obstetrics & Gynecology. doi: 10.1097/AOG.0000000000000981. July 31, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters